Literature DB >> 18289699

Human gene therapy vectors derived from feline lentiviruses.

Román A Barraza1, Eric M Poeschla.   

Abstract

Lentiviral vectors are useful for gene transfer to dividing and nondividing cells. Feline immunodeficiency virus (FIV) vectors transduce most human cell types with good efficiency and may have advantages for clinical gene therapy applications. This article reviews significant progress in the development and refinement of FIV vector systems.

Entities:  

Mesh：

Year:  2008        PMID： 18289699      PMCID： PMC2443640          DOI： 10.1016/j.vetimm.2008.01.009

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN： 0165-2427            Impact factor:   2.046


  81 in total

1.  Gene transfer to the brain using feline immunodeficiency virus-based lentivirus vectors.

Authors:  Colleen S Stein; Beverly L Davidson
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

Review 2.  Nonprimate lentiviral vectors.

Authors:  M A Curran; G P Nolan
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

3.  FIV Vectors.

Authors:  Nils Loewen; Roman Barraza; Todd Whitwam; Dyana T Saenz; Iris Kemler; Eric M Poeschla
Journal:  Methods Mol Biol       Date:  2003

4.  Genetic modification of human trabecular meshwork with lentiviral vectors.

Authors:  N Loewen; M P Fautsch; M Peretz; C K Bahler; J D Cameron; D H Johnson; E M Poeschla
Journal:  Hum Gene Ther       Date:  2001-11-20       Impact factor: 5.695

5.  Viral-mediated gene transfer to mouse primary neural progenitor cells.

Authors:  Stephanie M Hughes; Farid Moussavi-Harami; Sybille L Sauter; Beverly L Davidson
Journal:  Mol Ther       Date:  2002-01       Impact factor: 11.454

6.  Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors.

Authors:  Andrew J Lotery; Todd A Derksen; Stephen R Russell; Robert F Mullins; Sybille Sauter; Louisa M Affatigato; Edwin M Stone; Beverly L Davidson
Journal:  Hum Gene Ther       Date:  2002-04-10       Impact factor: 5.695

7.  Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha.

Authors:  Patrick L Sinn; Melissa A Hickey; Patrick D Staber; Douglas E Dylla; Scott A Jeffers; Beverly L Davidson; David A Sanders; Paul B McCray
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Feline immunodeficiency virus-mediated gene therapy of middle ear mucosa cells.

Authors:  Hamid R Djalilian; Yasuhiro Tsuboi; Masashi Ozeki; Muhammet Tekin; Ali R Djalilian; Wesley Obritch; Jizhen Lin
Journal:  Auris Nasus Larynx       Date:  2002-04       Impact factor: 1.863

9.  Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer.

Authors:  Jae Jin Song; Boyoung Lee; Jin Woo Chang; Joo-Hang Kim; Yunhee Kim Kwon; Heuiran Lee
Journal:  Virus Res       Date:  2003-05       Impact factor: 3.303

Review 10.  Restriction factors: a defense against retroviral infection.

Authors:  Paul D Bieniasz
Journal:  Trends Microbiol       Date:  2003-06       Impact factor: 17.079
View more
  12 in total

1.  Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates.

Authors:  Román A Barraza; Carol A Rasmussen; Nils Loewen; J Douglas Cameron; B'Ann T Gabelt; Wu-Lin Teo; Paul L Kaufman; Eric M Poeschla
Journal:  Hum Gene Ther       Date:  2009-03       Impact factor: 5.695

2.  Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.

Authors:  Albert Grinshpun; Reba Condiotti; Simon N Waddington; Michael Peer; Eli Zeig; Sima Peretz; Alina Simerzin; Janice Chou; Chi-Jiunn Pann; Hilla Giladi; Eithan Galun
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

3.  Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.

Authors:  Román A Barraza; Jay W McLaren; Eric M Poeschla
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

4.  Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag.

Authors:  Tahir A Rizvi; Julia C Kenyon; Jahabar Ali; Suriya J Aktar; Pretty S Phillip; Akela Ghazawi; Farah Mustafa; Andrew M L Lever
Journal:  J Mol Biol       Date:  2010-08-21       Impact factor: 5.469

5.  Identification of a genomic reservoir for new TRIM genes in primate genomes.

Authors:  Kyudong Han; Dianne I Lou; Sara L Sawyer
Journal:  PLoS Genet       Date:  2011-12-01       Impact factor: 5.917

6.  SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization.

Authors:  Julia C Kenyon; Sian J Tanner; Michal Legiewicz; Pretty S Phillip; Tahir A Rizvi; Stuart F J Le Grice; Andrew M L Lever
Journal:  Nucleic Acids Res       Date:  2011-05-05       Impact factor: 16.971

7.  Construction and testing of orfA +/- FIV reporter viruses.

Authors:  Hind J Fadel; Dyana T Saenz; Eric M Poeschla
Journal:  Viruses       Date:  2012-01-23       Impact factor: 5.048

8.  Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins.

Authors:  Alex C Stabell; John Hawkins; Manqing Li; Xia Gao; Michael David; William H Press; Sara L Sawyer
Journal:  PLoS Pathog       Date:  2016-12-27       Impact factor: 6.823

9.  Restriction of diverse retroviruses by SAMHD1.

Authors:  Thomas Gramberg; Tanja Kahle; Nicolin Bloch; Sabine Wittmann; Erik Müllers; Waaqo Daddacha; Henning Hofmann; Baek Kim; Dirk Lindemann; Nathaniel R Landau
Journal:  Retrovirology       Date:  2013-03-05       Impact factor: 4.602

10.  Promising Gene Therapeutics for Salivary Gland Radiotoxicity.

Authors:  Renjith Parameswaran Nair; Gulshan Sunavala-Dossabhoy
Journal:  AIMS Med Sci       Date:  2016-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.